Scan to Download
One power score. Smarter investment decisions
Mink Therapeutics Inc
INKT15.090USD
-0.260-1.69%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
60.21MMarket Cap
LossP/E TTM
Mink Therapeutics Inc
15.090
-0.260-1.69%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
Operating expenses
27.11%3.69M
-33.87%2.53M
-59.73%2.21M
-67.38%1.70M
-54.26%2.90M
-34.58%3.83M
-30.28%5.50M
-34.60%5.22M
-17.60%6.34M
-20.61%5.85M
24.99%7.89M
92.51%7.99M
72.90%7.70M
99.70%7.37M
--6.31M
--4.15M
--4.45M
--3.69M
R&D expenses
0.02%1.84M
-50.50%1.26M
-57.53%1.41M
-32.05%2.33M
-59.64%1.84M
-39.20%2.55M
-43.04%3.31M
-44.27%3.43M
-22.42%4.56M
-20.54%4.19M
47.14%5.81M
84.45%6.15M
10756.92%5.88M
16838.97%5.28M
--3.95M
--3.33M
--54.12K
--31.16K
Depreciation, depletion, and amortization
8.12%48.76K
-5.70%50.77K
0.55%53.87K
17.18%62.64K
-13.11%45.10K
17.83%53.83K
41.23%53.57K
88.02%53.45K
83.36%51.91K
68.73%45.69K
59.15%37.93K
40.15%28.43K
60.42%28.31K
67.20%27.08K
--23.83K
--20.29K
--17.65K
--16.19K
Other operating expenses
-100000.00%-999.00
----
--0.00
---1.79M
--1.00
----
----
----
----
----
----
----
----
----
----
----
--3.53M
--3.07M
Operating profit
-27.11%-3.69M
33.87%-2.53M
59.73%-2.21M
67.38%-1.70M
54.26%-2.90M
34.58%-3.83M
30.28%-5.50M
34.60%-5.22M
17.60%-6.34M
20.61%-5.85M
-24.99%-7.89M
-92.51%-7.99M
-72.90%-7.70M
-99.70%-7.37M
---6.31M
---4.15M
---4.45M
---3.69M
Net non-operating interest income (expenses)
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.55K
--881.32K
--805.05K
--743.70K
Special income (expenses)
-2436.01%-364.09K
---167.92K
---287.69K
---180.94K
--15.59K
----
----
----
----
----
100.00%0.00
100.00%0.00
100.00%0.00
-100.00%0.00
---49.43K
---8.87M
---1.16M
--684.44K
Other non-operating income (expenses)
-227.27%-185.70K
---79.53K
100.00%0.00
----
--145.91K
----
99.88%-18.00
-100.00%8.00
-100.00%0.00
100.00%0.00
-102.57%-15.37K
528.34%1.56M
1795.43%1.56M
-326.52%-401.96K
--598.74K
---364.84K
--82.27K
---94.24K
Income before tax
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Income after tax
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Net income from continuous operations
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Net income attributable to controlling interests
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Net income attributable to common shareholders
-56.85%-4.24M
27.45%-2.77M
54.88%-2.46M
64.69%-1.81M
56.40%-2.70M
32.94%-3.81M
29.75%-5.46M
19.20%-5.12M
-1.38%-6.20M
26.89%-5.69M
-34.79%-7.77M
55.62%-6.33M
3.51%-6.11M
-102.20%-7.78M
---5.76M
---14.27M
---6.34M
---3.85M
Basic earnings per share
-46.31%-1.06
36.61%-0.70
60.61%-0.62
69.19%-0.46
59.61%-0.73
34.25%-1.10
31.28%-1.58
20.93%-1.48
0.95%-1.80
27.88%-1.67
-25.76%-2.30
68.18%-1.88
75.07%-1.82
47.57%-2.32
---1.83
---5.89
---7.29
---4.43
Diluted earnings per share
-46.31%-1.06
36.61%-0.70
60.61%-0.62
69.19%-0.46
59.61%-0.73
34.25%-1.10
31.28%-1.58
20.93%-1.48
0.95%-1.80
27.88%-1.67
-25.76%-2.30
68.18%-1.88
75.07%-1.82
47.57%-2.32
---1.83
---5.89
---7.29
---4.43
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
